LORPUCITINIB
LORPUCITINIB JNJ 64251330 2230282-02-5 UNII-OE1QTY7C25 Molecular Weight408.50FormulaC22H28N6O2...
View ArticleTerlipressin acetate
Terlipressin acetate テルリプレシン酢酸塩 C52H74N16O15S2. (C2H4O2)x CAS: 914453-96-6 ACETATEFREE FORM 14636-12-5 Terlipressin acetate (JAN);Heamopressin (TN);Terlivaz (TN) Cardiovascular agent Antidiuretic,...
View ArticleEflapegrastim
Eflapegrastim エフラペグラスチム; Molecular Formula C15-H28-N2-O6(C2-H4-O)n Molecular Weight 376.4468 FormulaC3070H4764N806O927S23.(C2H4O)n UNII: UT99UG9QJX HM10460ASPI-2012 HNK460 Reducing neutropenia and the...
View ArticleGadopiclenol
Gadopiclenol ガドピクレノール; FormulaC35H54N7O15. GdCAS933983-75-6Mol weight970.0912 FDA APPROVED 2022/9/21, Elucirem Diagnostic agent (MR imaging), WHO 10744, P 03277, UNII: S276568KOY EluciremTM; G03277;...
View ArticleValemetostat tosilate
Valemetostat tosilate バレメトスタットトシル酸塩 FormulaC26H34ClN3O4. C7H8O3SCAS1809336-93-3Mol weight660.2205 PMDA JAPAN approved 2022/9/26, Ezharmia 1,3-Benzodioxole-5-carboxamide,...
View ArticleELRAGLUSIB
ELRAGLUSIB RN: 1034895-42-5UNII: ND1SOF0DLU, WHO 11553, 9-ING-41 1H-Pyrrole-2,5-dione, 3-(5-fluoro-3-benzofuranyl)-4-(5-methyl-5H-1,3-dioxolo(4,5-F)indol-7-yl)-...
View ArticleLutetium (177Lu) chloride
Lutetium (177Lu) chloride 塩化ルテチウム (177Lu) FormulaLu. 3ClCAS16434-14-3Mol weight281.326 2022/9/15 EMA 2022, Illuzyce EndolucinBeta (177Lu)lutetium(3+) trichloride Diagnostic aid, Radioactive agent...
View ArticleFutibatinib
Futibatinib フチバチニブ FormulaC22H22N6O3CAS1448169-71-8Mol weight418.4485 2022/9/30 FDA APPROVED, Lytgobi Antineoplastic, Receptor tyrosine kinase inhibitor DiseaseCholangiocarcinoma (FGFR2 gene fusion)...
View ArticleOzoralizumab
Ozoralizumab FormulaC1682H2608N472O538S12CAS 1167985-17-2Mol weight38434.3245 PMDA JAPAN APPROVED 2022 2022/9/26 Nanozora anti-TNFα Nanobody®; ATN-103; Nanozora; PF-5230896; TS-152 Ozoralizumab is a...
View ArticleDaxibotulinumtoxin A
Daxibotulinumtoxin A FDA APPROVED 2022 2022/9/7, Daxxify FormulaC6708H10359N1729O1995S32CAS93384-43-1Mol weight148171.4934 Daxibotulinumtoxin A-lanm Treatment of galbellar lines, cervical dystonia,...
View ArticleTremelimumab
(Light chain)DIQMTQSPSS LSASVGDRVT ITCRASQSIN SYLDWYQQKP GKAPKLLIYA ASSLQSGVPSRFSGSGSGTD FTLTISSLQP EDFATYYCQQ YYSTPFTFGP GTKVEIKRTV AAPSVFIFPPSDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD...
View ArticleTEREVALEFIM
TEREVALEFIM Molecular Formula C9-H8-N2-S Molecular Weight 176.2382 RN: 1070881-42-3UNII: GG91UXK2M5 5-((E)-2-Thiophen-2-yl-vinyl)-lh-pyrazole 1H-Pyrazole, 3-((1E)-2-(2-thienyl)ethenyl)- ANG-3777...
View ArticleMirvetuximab soravtansine-gynx
Mirvetuximab soravtansine-gynx FDA 11/14/2022,To treat patients with recurrent ovarian cancer that is resistant to platinum therapy Elahere FDA Approves Mirvetuximab Soravtansine-gynx for FRα+...
View ArticleTolebrutinib, SAR 442168
Tolebrutinib SAR442168 Treatment of Multiple Sclerosis (MS) CAS 1971920-73-6 PRN 2246, example 3 [WO2016196840A1] C26H25N5O3, 455.5 GTPL10625 BTK’168 EX-A4699 BDBM50557487 WHO 11268...
View ArticleABY 737
ABT-737 Molecular Weight813.43FormulaC42H45ClN6O5S2CAS No.852808-04-9 ABT-737 is a small molecule drug that inhibits Bcl-2 and Bcl-xL, two members of the Bcl-2 family of evolutionarily-conserved...
View ArticleOlutasidenib
Olutasidenib FT-2102 FT2102 C18H15ClN4O2 354.79 CAS1887014-12-1 Rezlidhia (Forma Therapeutics) SYN Caravella JA, et al. Structure-Based Design and Identification of FT-2102 (Olutasidenib), a Potent...
View Article